• OPEN AN ACCOUNT
Indian Indices
Sensex
77,235.46 -492.70
( -0.63%)
Global Indices
Nasdaq
53,489.46 -263.95
(-0.49%)
Dow Jones
7,767.06 -39.70
(-0.51%)
Hang Seng
67,388.40 -1,831.85
(-2.65%)
Nikkei 225
10,735.70 15.40
(0.14%)
Forex
USD-INR
95.53 0.14
(0.14%)
EUR-INR
110.53 0.55
(0.50%)
GBP-INR
129.27 0.59
(0.46%)
JPY-INR
0.60 0.00
(0.19%)

EQUITY - MARKET SCREENER

HDFC Nifty Banking ETF
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
543224
INF179KC1HY0
22.33
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HDFCNIFBAN
0
5700.27
EPS(TTM)
Face Value()
Div & Yield %
0
22.33
0
 

emco ltd
Lupin receives USFDA approval for Pitolisant Tablets, 4.45 mg and 17.8 mg
Aug 17,2026
Lupin has received the final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Pitolisant Tablets, 4.45 mg and 17.8 mg.

The U.S. FDA has approved Lupin's Pitolisant Tablets, 4.45 mg and 17.8 mg, as bioequivalent to Wakix® for the indications in the approved labeling.